Virginia Ruth Sanzone Sells 4,856 Shares of ICU Medical (NASDAQ:ICUI) Stock

ICU Medical, Inc. (NASDAQ:ICUI) VP Virginia Sanzone sold 4,856 shares of the business’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $168.69, for a total value of $819,158.64. Following the sale, the vice president owned 14,604 shares of the company’s stock, valued at approximately $2,463,548.76. This represents a 24.95% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

ICU Medical Stock Down 2.1%

Shares of NASDAQ:ICUI traded down $3.56 during trading on Thursday, reaching $166.29. 241,539 shares of the stock were exchanged, compared to its average volume of 290,811. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.43 and a quick ratio of 1.21. ICU Medical, Inc. has a 1-year low of $112.50 and a 1-year high of $192.85. The stock has a fifty day moving average of $166.61 and a two-hundred day moving average of $144.55. The firm has a market cap of $4.16 billion, a price-to-earnings ratio of 140.92, a price-to-earnings-growth ratio of 2.16 and a beta of 0.75.

ICU Medical (NASDAQ:ICUI) last issued its earnings results on Thursday, August 6th. The medical instruments supplier reported $2.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.91 by $0.46. ICU Medical had a return on equity of 7.91% and a net margin of 1.39%.The company had revenue of $547.88 million for the quarter, compared to analysts’ expectations of $533.44 million. During the same period last year, the business earned $2.10 EPS. ICU Medical’s quarterly revenue was up .5% compared to the same quarter last year. ICU Medical has set its FY 2026 guidance at 8.600-9.000 EPS. Research analysts anticipate that ICU Medical, Inc. will post 7.19 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ICUI has been the subject of a number of analyst reports. Sanford C. Bernstein cut shares of ICU Medical to a “market perform” rating in a report on Monday, June 15th. BTIG Research boosted their price objective on ICU Medical from $170.00 to $200.00 and gave the stock a “buy” rating in a report on Friday, August 7th. Weiss Ratings raised ICU Medical from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 23rd. Jefferies Financial Group upgraded ICU Medical to a “strong-buy” rating in a report on Thursday, May 7th. Finally, Wall Street Zen raised ICU Medical from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 8th. Two analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $192.80.

Institutional Investors Weigh In On ICU Medical

A number of institutional investors have recently added to or reduced their stakes in the company. AQR Capital Management LLC increased its stake in ICU Medical by 2.5% in the 1st quarter. AQR Capital Management LLC now owns 9,360 shares of the medical instruments supplier’s stock valued at $1,297,000 after buying an additional 229 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of ICU Medical by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,764 shares of the medical instruments supplier’s stock worth $1,772,000 after buying an additional 560 shares during the last quarter. United Services Automobile Association purchased a new position in shares of ICU Medical in the 1st quarter worth approximately $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of ICU Medical by 32.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 68,211 shares of the medical instruments supplier’s stock valued at $9,472,000 after acquiring an additional 16,680 shares in the last quarter. Finally, Intech Investment Management LLC grew its holdings in shares of ICU Medical by 38.6% in the first quarter. Intech Investment Management LLC now owns 11,938 shares of the medical instruments supplier’s stock valued at $1,658,000 after acquiring an additional 3,326 shares in the last quarter. 96.10% of the stock is owned by institutional investors.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.